Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tesomet PK study in healthy subjects
NCT03286829Phase 1Completed
- Sponsor
- Saniona
- Start
- Dec 2017
- Primary completion
- Feb 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, open-label trial of tesofensine in obesity and Prader-Willi syndrome (PWS), sponsored by Saniona. Started Dec 2017; status: completed.
02
Drugs
tesofensine
03
Conditions
obesityPrader-Willi syndrome (PWS)
Beyond the preview
Go deeper on NCT03286829.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03286829.